Skip to main content

Table 2 Demographics and lung function parameters in healthy and asthmatic control subjects and in athletes

From: Association of serum Clara cell protein CC16 with respiratory infections and immune response to respiratory pathogens in elite athletes

 

Healthy controls

Asthma controls

All athletes

Endurance athletes

Non-endurance athletes

No. of subjects

53

49

203

80

123

Males/Females

23/30

15/34

142/61

60/20

82/41

Age[years] (median; range)

28 (20-45)

29 (18-45)

26 (18-41)

25

26

Baseline FEV1 [% predicted] (median;range)

110 (77-126)

100 (75-123)

103 (66-129)

106 (82-126)

100 (66-129)

ΔFEV1post-salbutamol [%] (median; range)

ND

ND

4 (0-26)

4 (0-20)

4 (0-26)

MEF 25-75 [% predicted] (median; range)

104

80*

97 (38-170)

96 (42-170)

98 (38-163)

  1. *p < 0.05 vs. HC, all athletes, endurance athletes and non-endurance athletes;; ND, not done; HC, healthy controls